SR16157 / SRI International - LARVOL DELTA

Construction and clinical significance of prognostic risk markers based on cancer driver genes in lung adenocarcinoma. (PubMed, Clin Transl Oncol) - "This study identified 11 effective biomarkers, DE-CDGs, which can predict LUAD prognosis and explored the biological significance of CDGs in LUAD prognosis, immunotherapy, and treatment."

IO biomarker • Journal • Lung Adenocarcinoma • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor

Development of a prognostic model for lung adenocarcinoma polarity-related genes and analysis of immune landscape. (PubMed, Biotechnol Appl Biochem) - "XAV-939, Fulvestrant, and SR16157 may have potential value in the clinical use of LUAD. We revealed the potential linkage between PRGs and LUAD prognosis, and the application of these prognostic factors in risk stratification and prognosis prediction of LUAD patients may be of great significance."

Journal • Tumor mutational burden • Lung Adenocarcinoma • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • TMB